Kelly Michael Aaron
SEC insider (Form 3/4/5 filer). CIK 0001769668. Director at Prime Medicine, Inc. (PRME) and 3 other issuers. 22 reported Form 4/5 transactions since Sep 2024; latest on Jun 5, 2026. Located in FORT MYERS, FL.
Companies Kelly Michael Aaron has filed insider reports for
- Prime Medicine, Inc. (PRME): Director
- NEOGENOMICS INC (NEO): Director
- DMC Global Inc. (BOOM): Director
- AMICUS THERAPEUTICS, INC. (FOLD): Director
Kelly Michael Aaron
CIK: 0001769668
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (22 total)
- Jun 5, 2026PRME
Prime Medicine, Inc.
AwardDirectStock Option (right to buy)
75K shares- - Jun 1, 2026NEO
NEOGENOMICS INC
AwardDirectStock Option (Right to Buy)
11.1K shares- - Jun 1, 2026NEO
NEOGENOMICS INC
AwardDirectRestricted Stock Unit
16K shares- - Jun 1, 2026NEO
NEOGENOMICS INC
ExerciseDirect23.1K shares- - May 13, 2026BOOM
DMC Global Inc.
AwardDirect16.9K shares- - Apr 27, 2026FOLD
AMICUS THERAPEUTICS, INC.
DispositionDirect72.5K shares at avg. $14.50$1.1M - Aug 1, 2025PRME
Prime Medicine, Inc.
DispositionDirectStock Option (right to buy)
9K shares- - Aug 1, 2025PRME
Prime Medicine, Inc.
DispositionDirectStock Option (right to buy)
39.1K shares- - Aug 1, 2025PRME
Prime Medicine, Inc.
AwardDirectStock Option (right to buy)
13.5K shares- - Aug 1, 2025PRME
Prime Medicine, Inc.
DispositionDirectStock Option (right to buy)
13.5K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 5, 2026 |  PRME Prime Medicine, Inc. | Award Stock Option (right to buy) | 75,000 | - | - | Direct |
| Jun 1, 2026 |  NEO NEOGENOMICS INC | Award Stock Option (Right to Buy) | 11,069 | - | - | Direct |
| Jun 1, 2026 | NEO NEOGENOMICS INC | Award Restricted Stock Unit | 15,970 | - | - | Direct |
| Jun 1, 2026 | NEO NEOGENOMICS INC | Exercise | 23,077 | - | $0 | Direct |
| May 13, 2026 |  BOOM DMC Global Inc. | Award | 16,937 | - | $0 | Direct |
| Apr 27, 2026 |  FOLD AMICUS THERAPEUTICS, INC. | Disposition | 72,468 | $14.50 | $1,050,786 | Direct |
| Aug 1, 2025 | PRME Prime Medicine, Inc. | Disposition Stock Option (right to buy) | 9,006 | - | - | Direct |
| Aug 1, 2025 | PRME Prime Medicine, Inc. | Disposition Stock Option (right to buy) | 39,062 | - | - | Direct |
| Aug 1, 2025 | PRME Prime Medicine, Inc. | Award Stock Option (right to buy) | 13,510 | - | - | Direct |
| Aug 1, 2025 | PRME Prime Medicine, Inc. | Disposition Stock Option (right to buy) | 13,510 | - | - | Direct |
1-10 of 22 transactions